Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing

Trump to unveil Medicare drug pricing plan after teasing "earth-shattering" announcement

President Trump will introduce a "most favored nation" plan aimed at cutting Medicare drug prices by linking them to the prices of medication abroad, sources told CBS News.

Pharmalittle: We're reading about a Trump drug-pricing plan, a new FDA official trying to rally staff, and more

Top of the morning to you, and a fine one it is. Crystal clear blue skies and pleasant breezes are enveloping the Pharmalot campus, where the official mascots are attempting to intimidate various creatures and the commuter traffic is whizzing by. As for us, we are busy brewing another cup of stimulation. Our choice today is hazelnut creme, an old standby. Please feel free to join us. Of course, we are also prowling for items of interest and are …

Trump Directs FDA, EPA to Reduce Regulatory Barriers to Domestic Pharma Manufacturing

The White House is instructing FDA to increase fees for and inspections of foreign drug manufacturing plants and reduce the time required to approve such sites that will be newly constructed in the US.

FDA Expands Unannounced Inspections at Foreign Manufacturing Facilities // Cooley // Global Law Firm

Gilead reveals plans to put another $11B into US manufacturing

Gilead is the latest pharma company to announce that it’s pouring billions of dollars into its manufacturing and R&D operations in the US. The company said Wednesday that it’s investing a ...

FDA plans to expand unannounced inspections of foreign drug plants  - Pharmaceutical Technology

This move comes a day after President Trump signed an executive order to streamline approval processes for domestic plants.